The Univeristy of Melbourne The Royal Melbourne Hopspital

A joint venture between The University of Melbourne and The Royal Melbourne Hospital

Dr Romain Guerillot


Romain Guerillot is a molecular microbiologist and data scientist specialised in bacterial functional genomics. Following his PhD graduation in 2014 at the Pasteur Institute of Paris he joined the research teams of Prof. Ben Howden and Prof. Tim Stinear. Using large scale data analysis, Romain combines innovative computational and experimental approaches to understand and fight antibiotic resistant bacterial pathogens. He is currently working on multiple research projects focusing on understanding how Staphylococcus aureus, a bacteria colonising ~20% of humans, can cause deadly infections.

  • Key Achievements
    • Romain graduated from a Master’s Degree with Distinction in Cellular and Molecular Biology at the Pierre et Marie Curie University in Paris. In 2013, he completed a PhD with honours on mobile genetic elements of Streptococcus agalactiae under the supervision of Philippe Glaser within the laboratory ‘Biology of Gram-Positive Pathogens of the Institut Pasteur in Paris. His PhD led to the characterisation of new families of mobile genetic elements widespread amongst gram positive bacteria, and to the development of new genetic tools to manipulate streptococci. Romain is co-author of a book chapter and his PhD work has been published in peer reviewed scientific journals and presented in several international and national conferences.

    Publications
    Loading ORCID data…
    Research Groups
    • Howden Group

      Research from Professor Ben Howden’s group uses genomics, molecular biology, epidemiology and clinical studies to address a broad range of issues related to invasive bacterial diseases in humans, especially those caused by staphylococci, enterococci and other antimicrobial-resistant species. Additionally, working closely with scientists in the MDU PHL, they investigate the epidemiology, evolution and spread of bacterial pathogens of public health significance such as Neisseria gonorrhoea, Listeria monocytogenes, Shigella and Salmonella spp., Legionella spp., and carbapenemase-producing gram-negative bacteria.


      Lab Team

      Howden Group

    • Stinear Group

      Tim Stinear’s group’s research addresses priorities across four connected themes that including hospital superbugs, pathogenic mycobacteria, natural product discovery and public health genomics that aim to understand and contain the spread of bacteria causing serious human disease. 


      Lab Team

      Stinear Group

      • Laboratory Head and Director of the WHO Collaborating Centre for Mycobacterium ulcerans
      • Postdoctoral Researcher
      • Senior Researcher
      • Infectious Diseases Physician | Medical Education Consultant | PhD Candidate
      • Research Fellow
      • Jessica Porter
        Research Assistant
      • Kirstie Mangas
        PhD Candidate
      • Andrew Buultjens
        PhD Candidate

Full University of Melbourne profile